REQUEST A DEMO
Total
USD $0.00
Search more companies

Veyx Pharma Spol. S R.O. Nitra (Slovakia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers | Other Miscellaneous Nondurable Goods Merchant Wholesalers
Secondary Activities: Other Miscellaneous Nondurable Goods Merchant Wholesalers
Full name: Veyx Pharma Spol. S R.O. Nitra Profile Updated: July 22, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Veyx Pharma Spol. S R.O. Nitra is a company in Slovakia, with a head office in Luzianky. The company operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. The enterprise was incorporated on March 08, 1993. It currently has a total number of 3 - 4 (2025) employees. In 2024, the company reported a net sales revenue increase of 18.32%. There was a total growth of 18.73% in Veyx Pharma Spol. S R.O. Nitra’s total assets over the same period. The net profit margin of Veyx Pharma Spol. S R.O. Nitra decreased by 3.81% in 2024.

Headquarters
Rastislavova, 79
Luzianky; Nitriansky; Postal Code: 94941

Contact Details: Purchase the Veyx Pharma Spol. S R.O. Nitra report to view the information.

Basic Information
Total Employees:
Purchase the Veyx Pharma Spol. S R.O. Nitra report to view the information.
Registered Capital:
Purchase the Veyx Pharma Spol. S R.O. Nitra report to view the information.
Financial Auditors:
Purchase the Veyx Pharma Spol. S R.O. Nitra report to view the information.
Incorporation Date:
March 08, 1993
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Attorney
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Veyx Pharma Spol. S R.O. Nitra report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
18.32%
Total operating revenue
13.08%
Operating profit (EBIT)
-27.33%
EBITDA
-28.63%
Net Profit (Loss) for the Period
-27.79%
Total assets
18.73%
Total equity
15.34%
Operating Profit Margin (ROS)
-4.87%
Net Profit Margin
-3.81%
Return on Equity (ROE)
-7.94%
Debt to Equity Ratio
-0.97%
Quick Ratio
-0.72%
Cash Ratio
-1.01%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?